Here is my fundraising profile for the local chapter of the American Cancer Society. https://www.facebook.com/MichianaRMWP/posts/1321606701327331
Category Archive: Harper Cancer Research Institute
Apr 08
Label-Free, Magnetic Nanocarrier based, Precision Combinatorial Chemotherapeutics Treatment Against Metastatic Cancer for Recurrence-Free Survival
╪1,3Margo Waters, ╪1,3Juliane Hopf, 1,3Paul Helquist, 2Vincent Jo Davisson, and 1,3Prakash. D. Nallathamby 1University of Notre Dame, Notre Dame USA; 2Purdue University, Lafayette, USA; 3NDnano, Notre Dame, USA ╪ Equal contributors The leading cause of fatalities in breast cancer is metastasis.1 To increase the success rate of metastasis-free survival, there is a need to tackle …
Feb 14
American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo
We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …
Feb 11
Read our review article on novel ‘Blue-sky’ future applications of nanoparticles in the Biomedical Field
Over the last two decades, nanotechnology has become one of the most dynamically evolving field of research. Various types of nanoparticles are widely exploited to extend our understanding of biological interactions at the molecular level. They are actively engaged in the biomedical research for imaging, biosensing, drug delivery and/or concurrent therapy. Recent progress on this …
Nov 28
Nallathamby Laboratory in the Press for Novel Approach to CAR-T Therapy
Glad to see that our work on using nanoparticle-based ON-OFF switches for CAR-T cells therapy against solid tumors is getting positive traction in the local media. Here is my interview with Kylie Veleta of Inside Indiana business on what motivates us to keep pushing forward. The website is Indiana business focused. The interview was part …
May 01
CD133+ Cancer Stem Cells Role in Metastasis
Excited for the 2nd publication this year through collaborative efforts with Harper Cancer Research Institute’s Karen Dahl (Title: CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche). I did the 3D confocal imaging that showed CD133+ ovarian cancer cells clearly penetrate the basal epithelial cells, pointing to metastatic potential of stem cell like cancer cells. Looking …
NIH Funding Opportunities
- NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed) November 21, 2024Funding Opportunity RFA-NR-25-002 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications from multidisciplinary teams of experts in firearm injury prevention research across departments and institutions to develop and provide research resources and support to build capacity among United States (U.S.) nurse researchers for rigorous, high-impact research in […]
- Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R41 - Clinical Trials Optional) November 21, 2024Funding Opportunity RFA-DA-26-017 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research and development of medical devices specifically indicated for pediatric population (i.e., 0-21 years old, as defined by the FDA Center for Devices and […]
- Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R43 - Clinical Trials Optional) November 21, 2024Funding Opportunity RFA-DA-26-016 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research and development of medical devices specifically indicated for pediatric population (i.e., 0-21 years old, as defined by the FDA Center for Devices and […]
- NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) November 21, 2024Funding Opportunity PAR-25-261 from the NIH Guide for Grants and Contracts. The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. […]
- Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R21 Clinical Trial Not Allowed) November 21, 2024Funding Opportunity RFA-MH-26-111 from the NIH Guide for Grants and Contracts. Eradicating latent reservoirs of HIV-1 within the body and achieving a sterilizing or functional cure have become priority areas in the AIDS field and NIH AIDS programs across many Institutes and Centers, including NIMH. In addition understanding the mechanisms of HIV- associated co-morbidities in […]
- Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R01 Clinical Trial Not Allowed) November 21, 2024Funding Opportunity RFA-MH-26-110 from the NIH Guide for Grants and Contracts. Eradicating latent reservoirs of HIV-1 within the body and achieving a sterilizing or functional cure have become priority areas in the AIDS field and NIH AIDS programs across many Institutes and Centers, including NIMH. In addition understanding the mechanisms of HIV- associated co-morbidities in […]
- Notice of Early Expiration of PAR-22-138, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)" November 21, 2024Notice NOT-MH-25-076 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-22-137, Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) November 21, 2024Notice NOT-MH-25-075 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of "Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine", NOT-AI-22-013 November 21, 2024Notice NOT-AI-24-084 from the NIH Guide for Grants and Contracts
- Webinar for Notice of Special Interest (NOSI): Training Modules for Enhancing Biomedical Research Workforce Training November 21, 2024Notice NOT-GM-25-009 from the NIH Guide for Grants and Contracts
Recent Comments